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CHAPTER I 
 
INTRODUCTION 
 
Nutrients significantly influence health and disease in the management 
of both minor and major medical illnesses as fast growing field in research. 
Different fatty acids and other lipids like cholesterol and its derivatives are 
examples of nutrients capable of regulating their own metabolism as well 
as general energy turnover in many organs. Mitochondria play a key role in 
energy metabolism in many tissues, for example in the key metabolic 
tissues skeletal muscle, liver, and adipose tissue (Rolfe & Brown, 1997); as 
the main site of the oxidative process, changes in their metabolic activity 
could result from changes in mitochondrial mass and specific capacity 
(Iossa et al.  2002).  
Chronic elevation of plasma fatty acid levels is a characteristic feature 
of obese diabetic and non-diabetic individuals (Opie LH and Walfish PG 
1963), where increased levels of intracellular lipid intermediates like acyl-
CoAs, DAGs activating protein kinase c – theta (PKC- Ѳ) and IκB kinase 
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β (IKKβ) interfere with intracellular insulin signaling; leading to an 
unfavorable balance between fatty acid catabolism to CO2 and the onset of 
β oxidation. Sustained oversupply of metabolic fuel (glucose and fatty 
acids), as seen during type II diabetes (T2D) and obesity, impairs the 
ability of mitochondria to shift between use of lipid during fasting and use 
of carbohydrate in the post-prandial state, which is critically important for 
energy homeostasis. This metabolic inflexibility imposes a major substrate 
burden on the oxidative machinery of muscle and the continued oversupply 
of carbon fuel eventually surpasses the respiratory drive and cellular 
demand for ATP synthesis.  
Fatty acids (FAs) undergo incomplete oxidation and greater 
partitioning into lipotoxic derivatives (e.g. diacylglycerol (DAG) and 
ceramides) that have been strongly implicated in the pathogenesis of 
insulin resistance (Yu C et al., 2002). Reactive oxygen species (ROS) 
generation associated with mitochondrial overload has been strongly 
implicated as a stimulus promoting expression/signalling of 
proinflammatory proteins that may further dysregulate mitochondrial 
function by suppressing expression of PGC1α (a major regulator of 
mitochondrial biogenesis) and of genes encoding components of the 
respiratory chain.  
Increased supply of certain FAs has an effect on processes regulating 
fuel and energy balance within skeletal muscle and liver. In particular, 
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saturated fatty acids impair Akt signalling to key end-points of insulin 
action such as glucose uptake; inhibit major ATP-consuming processes 
(e.g. DNA and protein synthesis). Reduced mitochondrial respiratory 
capacity has also been linked to aberrant control of skeletal muscle 
mitochondrial dynamics.  
The anti-inflammatory AMPK action may itself be a consequence of 
the kinase alleviating substrate-induced mitochondrial stress by: (i) 
promoting FA oxidation, (ii) restraining mitochondrial ROS production 
and (iii) stimulating mitochondrial biogenesis via modulation of PGC1α-
dependent transcriptional activity. It has been suggested that PPARα 
activation in the liver might be related to the anti-obesity and anti-steatotic 
effects. This was concomitant with improved insulin sensitivity and insulin 
action in skeletal muscle and liver, and ameliorated glucose tolerance in 
these mice, suggesting a potential therapeutic activity for ω-3 in obesity 
(White PJ et al. 2010). 
Therefore, the amount and type of fat in the diet can play an important 
role in regulating whole body metabolic health.  In particular, diets high in 
saturated fat have been linked with the onset of both obesity and T2D 
(Vessby B et al., 2001; Summers L.K.M et al., 2002).  Remarkably, 
provision of polyunsaturated fatty acids confers protection against 
mitochondrial insufficiency and counters the proinflammatory and insulin 
desensitising effects of saturated fat (Ebbesson S.O.E. et al., 2005; Bang 
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H.O et al., 1980). PUFAs may be linked to reduced ROS generation which 
is a feature of mitochondrial uncoupling. This project aims to investigate 
the influence of different quality of dietary fatty acids on the metabolic 
processes focusing on the role played by the mitochondria in the sites with 
highest metabolic activity such as liver and skeletal muscle. This study 
could be useful to explore new mechanistic insight and opportunities for 
treating obesity-induced insulin resistance and its associated metabolic 
disorders. 
Our work will determine if PUFA from fish oil and cow milk mediates 
its effect via AMPK; a molecule that crucially regulates cellular energy 
balance.  
 
Obesity and Diabetes mellitus  
               Obesity arises from an imbalance between energy intake and 
expenditure increasing the risk of developing diabetes (Schmidt M et al., 
2013). The prevalence of obesity has been rising globally during the last 
century. According to the latest projections by the World Health 
Organization (WHO) approximately 2.3 billon adults will be overweight 
and more than 700 million obese worldwide by the year 2016. Obesity, 
T2D and insulin resistance are interconnected so strongly and termed as 
metabolic syndrome (Luna-Luna M et al., 2015). 
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Diabetes mellitus can be classified as type 1, type 2, or maturity onset 
diabetes of the young (MODY) which accounts for a number of hereditary 
forms of diabetes caused by genetic mutations. Type 1diabetes, also 
referred to as juvenile or insulin-dependent diabetes is a result of an 
autoimmune destruction of β cells which leads to a loss of insulin 
production. Alternatively, type 2 diabetes, termed insulin-independent, is 
the most common form of diabetes, comprising 90–95% of those 
diagnosed. This type is caused by a combination of genetic predisposition 
and environmental pressures that result in the progressive desensitization 
of peripheral tissues to insulin. This reduction in sensitivity triggers the 
existing β cells to produce more insulin, leading to increased 
desensitization of the β cells, and this cycle ultimately leads to decreased β 
cell function and β cell death, which results in hyperglycaemia. 
 
Insulin Resistance 
Fatty liver, oxidative stress and mitochondrial dysfunction are key 
pathophysiological features of insulin resistance and obesity and type 2 
diabetes. Reduced response to insulin (i.e. insulin resistance) may affect 
several organs, but skeletal muscles, liver and adipose tissues seem to play 
the major roles in insulin-induced glucose clearance with reduced capacity 
for complete mitochondrial fatty acid oxidation. (Schenk S et al., 2008) 
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Insulin regulated glucose metabolism: 
a. In skeletal muscle and adipose tissue, insulin enhances glucose uptake 
by translocation and fusion of intracellular vesicles containing the 
specific glucose transporter GLUT4. Skeletal muscle may further 
accumulate the incoming glucose as glycogen or catabolize it partly to 
lactate, or completely to CO2 by mitochondrial oxidation. Adipocytes on 
the other hand do not generate glycogen or oxidize glucose to a 
significant extent; instead glucose is utilized to produce the glycerol 
backbone of TAGs, or broken down to acetate in mitochondria and to be 
further utilized as substrates for de novo fatty acid synthesis via the 
enzyme fatty acid synthase (FAS) located in the cytosol. Insulin also 
increases fatty acid uptake in skeletal muscle and adipocytes, and 
inhibits lipolysis of TAG stored in adipose depots.  
 
b. In the liver, however, insulin functions differently as the liver cells do 
not exhibit GLUT4-mediated insulin-stimulated glucose uptake. Instead 
glucose uptake is regulated downstream of membrane transport 
(facilitated by GLUT2) by a liver specific hexokinase (also called 
glucokinase; GK) (Matschinsky FM et al., 2006; Okamoto Y et al., 
2007) e) and glutathione synthetase (GS), the rate limiting step in 
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glycogen synthesis.  Glucose entering the hepatocyte may become 
incorporated into glycogen, oxidized or used as substrate for de novo 
fatty acid synthesis. Insulin regulates glycogen synthesis positively and 
gluconeogenesis negatively, thereby increasing storage and reducing 
output of hepatic glucose into the blood stream, respectively. 
 
 
 
 
 
 
 
 
Fig 1.1. Insulin regulated glucose metabolism (Hvammen AW, 2010): The fate of glucose 
entering the blood after a meal and responses to insulin. After entering the cell, glucose may either 
be stored as glycogen (mainly in skeletal muscle and liver), catabolized partly to lactate by working 
muscle exceeding its oxidative capacity, converted to glycerol to form the backbone of TAG 
(mainly adipocytes), catabolized completely to CO2 to produce energy carriers like ATP and NADP 
(most organs including brain). In adipose tissue glucose may also be oxidized to acetate and be 
further utilized as substrates for de novo fatty acid synthesis via FAS. Glucose transporter 1,2 
(GLUT1,2), fatty acid synthase (FAS), fatty acid (FA), triacylglycerol (TAG), non-esterified fatty 
acid (NEFA), very low density lipoprotein (VLDL), adenosine triphosphate (ATP).  
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The aim of this thesis was to examine the influence of high forage 
milk on hepatic function. Since, in our previous studies, we had observed 
the effects of different milk on skeletal muscle, in the current study we 
focused on the effects of different fatty acids administration on skeletal 
muscle mitochondria. 
Liver: Plays a main role in energy expenditure and lipid and glucose 
metabolism by conversion of carbohydrates into fatty acids, but a small 
part of triglycerides is synthesized in adipocytes. Although fatty acids and 
triglycerides synthesis take place in the cytosol, mitochondria provide key 
intermediates needed for lipogenesis, like glycerol 3-phosphate and acetyl-
CoA. Key enzyme in glycerol 3-phosphate synthesis is mitochondrial 
pyruvate carboxylase that converts pyruvate into oxaloacetate. Pyruvate 
also undergoes decarboxylation to acetyl-CoA by the mitochondrial 
pyruvate dehydrogenase complex, which facilitates fatty acid and 
triglyceride synthesis. As liver greatly contributes to whole-body energy 
expenditure and lipid utilization (Yu T et al., 2006), thus protein mass, 
oxidative capacity and energy efficiency were evaluated in mitochondria 
isolated from the liver of differently treated rats with milk from cows fed 
with high forage.  
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Skeletal muscle 
Skeletal muscle constitutes the largest organ in the body accounting 
for approximately 40% of body weight in normal individuals (Snyder WS 
et al., 1975). The share mass of this organ renders its importance for 
energy homeostasis, and even at rest it utilizes approximately 30% of total 
body energy expenditure, whereas during hard physical activity energy 
expenditure rises several-fold (Zurlo F et al., 1990). Lack of muscle 
activity has been associated with increased risk of developing obesity, T2D 
and cardiovascular diseases (Hamilton MT et al., 2007), and reduced 
muscle energy turnover is associated with development of both obesity 
(Zurlo F et al., 1990) and T2D (Handschin C et al., 2008). Glucose and 
fatty acids are quantitatively the primary energy sources for skeletal 
muscle, with resting muscles consuming more fatty acids during fasting, 
and more glucose when carbohydrate uptake increases postprandially 
(Kelley DE et al., 1993). Skeletal muscles are responsible for more than 
80% of insulin-stimulated glucose disposal (DeFronzo RA et al., 1981). 
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Mitochondrial metabolism, dysfunction & metabolic disorders 
Mitochondria are essential for the maintenance of normal 
physiological function of tissue cells and mitochondrial dysfunction often 
accompanies and underlies the pathogenesis of disease (Wang C.H et al., 
2010). Mitochondria are the cytoplasmic organelles in human and animal 
cells that house crucial metabolic processes like fatty acid oxidation, 
oxidative phosphorylation, and ROS production. It is not surprising that 
impaired mitochondrial activity often has an association with metabolism 
by contributing to (i) oxidative stress and (ii) insulin resistance, (iii) 
genetic factors’ (N. Turner and L. K. Heilbronn 2008).  
The principal role of mitochondria is to synthesize more than 95% of 
adenosine triphosphate (ATP) for cellular utilization (Wang C.H et al., 
2010). Production of ATP requires two major steps, oxidation of highly 
reducing metabolites and coenzymes such as nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide (FADH2) and 
phosphorylation of adenosine diphosphate to generate ATP to support 
various cellular functions (OXPHOS, oxidative phosphorylation) (Kim J.A 
et al., 2008).  
The mitochondrial respiratory system consists of four enzymatic multi 
heteromeric complexes (I–IV) embedded in the inner membrane of 
mitochondria and two individual mobile molecules, coenzyme Q (CoQ) 
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and cytochrome c, along which the electrons liberated by the oxidation of 
NADH and FADH2 are passed and ultimately transferred to molecular 
oxygen. This respiratory function creates the electrochemical gradient of 
protons by a mechanism called “proton leak” and reduce membrane 
potential (ΔΨ) generating heat instead of energy about 180 mV through the 
inner membrane that has the potential to do work (Kim J.A et al., 2008).  
Given their central role in energy production, it is perhaps not 
surprising that mitochondrial dysfunction has been implicated in the 
aetiology of skeletal muscle insulin resistance, a precursor of frank 
diabetes. The higher levels of lipid intermediates in insulin resistant 
subjects could be a consequence of a lower fat oxidative capacity, which is 
low in insulin resistance. This blunted oxidative capacity is due to fewer 
mitochondria and/or compromised mitochondrial function. In combination 
with elevated intramyocellular lipids content, mitochondrial dysfunction 
could result in increased availability of lipid intermediates (Nielsen J et al., 
2010). 
Oxidative stress 
 Mitochondria are also deeply involved in the production of reactive 
oxygen species (ROS) through electron carriers in the respiratory chain 
(Lenaz G, 1998) leading to a disturbance in the balance between the 
production of ROS and antioxidant defence (Betteridge D. J, 2000). 
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Mitochondria are a major source of cellular free radicals that might 
damage proteins, lipids, and DNA. Defects in the transfer of electrons 
across the mitochondrial membrane can cause electrons to accumulate on 
the respiratory chain complexes, which results in an increase of the 
potential for electrons to bind with free oxygen and stimulation of ROS 
production (Johannsen D. L and Ravussin E, 2009). Furukawa et al. have 
shown that elevated levels of fatty acids increased oxidative stress via 
NADPH oxidase activation in cultured adipocytes causing dysregulated 
production of various adipokines (Furukawa S et al., 2004). 
 
Mitochondrial activity insulin resistance and metabolic dysfunction in 
skeletal muscle 
The influence of nutrition on skeletal muscle has the potential to 
substantially impact whole body metabolism. Skeletal muscle constitutes 
the largest organ in the body plays a well-established role in maintaining 
glucose homeostasis and defects in optimal muscle insulin sensitivity and 
function cause metabolic disease (Abdul-Ghani MA etal., 2010). Skeletal 
muscle (depending on adiposity levels) accounts for approximately 40% of 
total body mass and is highly adaptable to environmental changes such as 
diet and physical activity levels (Zhao X  et al., 2013; Kim J et al., 2002). 
Skeletal muscle is a major site of glucose disposal (Meyer C et al., 2002, 
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Kelley DE e al., 1993). Since ATP is not stored within skeletal muscle in 
great abundance (∼20–25 mmol (kg dry muscle)−1), during heightened 
metabolic demand there is an essential requirement for rapid and sustained 
ATP production, a role fulfilled primarily by mitochondria. As such, 
skeletal muscle cells are densely populated with these complex organelles.  
Maintaining skeletal muscle metabolic health is therefore key to 
maintain glycaemic control. Strategies that improve skeletal muscle 
metabolic function and insulin sensitivity could therefore have a major 
impact on the obesity induced development of insulin resistance and 
diabetes to improve quality of life. Circulating fatty acids in the muscle can 
be incorporated into triacylglycerol (TAG), which is the main component 
of Intromyocellular lipids (IMCL), i.e. saturated fats inside the cells 
predominantly dispersed into small lipid droplets throughout the muscle 
cells interfering with the action of the insulin receptor’s, making the cells 
resistant to insulin (DeFronzo RA et al., 1981) or can be oxidized by the 
mitochondria. In TAG synthesis, three fatty acids bind to glycerol. The 
first step in the TAG formation is an ester bond between one fatty acid and 
glycerol, resulting in monoacylglycerol (MAG). Subsequently another 
fatty acid is bound to MAG facilitated by MGAT forming diacylglycerol 
(DAG). The final step for TAG formation is the addition of a third fatty 
acid to DAG by DGAT. TAG is the final product of this chain of anabolic 
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processes designed for storage of energy, and this storage occurs in small 
TAG-containing lipid droplets. 
Lipolysis of TAG occurs when fatty acids are required for oxidation. 
In this process fatty acids are subsequently released from glycerol. Upon 
complete lipolysis this results in the release of three fatty acids. The first 
step in lipolysis is catalyzed by adipose triglyceride lipase (ATGL) 
resulting in DAG and one fatty acid. 
Subsequently another fatty acid is hydrolyzed from glycerol catalyzed 
by hormone sensitive lipase (HSL). Finally, MAG is hydrolyzed by 
monoglyceride lipase (Bergman BC et al., 2012). Lipid droplet lipolysis is 
a complex and strictly orchestrated process with many more players like 
(co-) activators and suppressors involved. Spillover of fatty acids from the 
white adipose tissue along with a reduced fat oxidative capacity may 
promote fat storage in muscle.   
 
Inflammatory signalling pathway and insulin resistance degree in 
skeletal muscle Inflammation is a key component of the etiology of 
obesity-linked insulin resistance and type 2 diabetes (T2D) (White PJ et 
al., 2008). Metabolic targets for the prevention and treatment of insulin 
resistance such as adiponectin have been shown to counter-regulate 
inflammation. Consequently, developing our understanding of mechanisms 
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involved to allow development of novel strategies aimed at preventing the 
development or limiting the progress of inflammation are of great interest 
to the field.  
We seek to define the role of one of the key player in metabolism, e.g. 
the AMP-activated protein kinase (AMPK), an energy sensor and a potent 
counter-regulator of inflammatory signaling pathways (Salt and Palmer 
2012; Hernández-Aguilera et al., 2013). Adenosine monophosphate-
dependent kinase (AMPK), an evolutionary conserved serine/threonine 
kinase, is a hetero trimeric complex formed by a catalytic a subunit and 
regulatory b and g subunits. The phosphorylation of the a subunit, at Thr 
172, turns AMPK into the activated form pAMPK.  AMPK is a sensor of 
the cellular energy status that, when activated by metabolic stress, is able 
to maintain cellular energy homeostasis. 
Tumour necrosis factor-α (TNF-α) is also known to induce IR through 
the phosphorylation of IRS-1 on serine 307 similar to lipid intermediates 
(Aguirre V  et al., 2000) and EPA reduces TNF-α expression (Figueras M  
et al.,2011). Furthermore, in macrophages and adipocytes the G-protein 
coupled receptor GPR120 is an omega-3 sensitive receptor that exhibits 
anti-inflammatory properties through the suppression of TNF-activation. 
While transient inflammation is an important process in muscle adaptation, 
failure to effectively resolve inflammation leading to a chronic state of 
inflammation is associated with IR/T2D and obesity (Arkan MC et al., 
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2005). There is growing evidence that omega-3 PUFAs have potent anti-
inflammatory actions (Calder, P.C 2010). Synergistically, EPA and DHA 
play a role in the resolution of inflammation through the EPA and DHA 
derived inflammatory mediators (Stables MJ et al., 2011) such as 
prostaglandins, leukotrienes, lipoxins, resolvins and protectins. The anti-
inflammatory effect of EPA and DHA are predominantly dependent on 
incorporation into phospholipids. Although inflammation may not have a 
primary role in the development of IR in skeletal muscle, it may accentuate 
the metabolic dysfunction caused by the onset of IR/T2D (Turner N et al., 
2013). Furthermore, a number of animal studies where inflammatory 
pathways are genetically down regulated demonstrate that preventing 
obesity induced inflammation can prevent the development of insulin 
resistance (Uysal K.T et al., 1997).  
Controlling inflammation may, therefore, be an important factor in the 
long term management of skeletal muscle IR by assessing the immune 
modulatory effect of omega-3 PUFAs.  
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Fig 1. 2. Inflammation and related cellular events in obesity (André Marette et al., 2014): 
resolution by ω-3 PUFA derived mediators and adiponectin. In obesity, a vicious cycle of cellular 
events ensues and the crosstalk between these exacerbates the associated clinical complications. 
Evidence suggests that LC ω-3 PUFA-derived mediators reduce inflammation and improve insulin 
sensitivity by numerous mechanisms, one of which is via enhancing adiponectin action. 
 
Adiponectin, insulin resistance and skeletal muscle metabolism 
Various dietary and nutritional factors have the capacity to enhance 
adiponectin expression (Li FY etal., 2012). Recent evidence suggests that 
mitochondria in adipose tissues might play plentiful roles in the regulation 
of the whole body energy homeostasis. By this study we aim to understand 
the molecular mechanisms of action via which inflammation, insulin 
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resistance and metabolic dysfunction occur in skeletal muscle, and also 
how they crosstalk with each other by contributing role of adiponectin and 
inflammation, so that we can generate new and improved therapies for 
obesity-linked metabolic complications. Adiponectin plays an important 
role in the pathophysiology of diabetes in obesity via regulating 
metabolism in skeletal muscle (Liu Y et al., 2014).   
Adiponectin is a white and brown adipose tissue hormone, known as 
highly abundant plasma gelatin-binding protein-28 (GBP28), AdipoQ, 
adipocyte complement-related protein (ACRP30), or apM1 (~2–20 ug/ml) 
and a decreased level is observed in obese individuals and this correlates 
strongly with various features of the metabolic syndrome. The beneficial 
effects of adiponectin, including anti-inflammatory and insulin-sensitizing 
actions, have been well established (Yamauchi T et al., 2013) that exerts its 
action through its receptors AdipoR1, AdipoR2, and T-cadherin. AdipoR1 
is expressed abundantly in muscle, whereas AdipoR2 is predominantly 
expressed in the liver. Adiponectin increases fatty acids oxidation, which 
lowers circulating free fatty acids and prevents insulin resistance with 
distinct potential for being of therapeutic value (Adeeb Shehzad et al., 
2012). 
Adiponectin directly stimulates fatty acid metabolism in skeletal 
muscle by increasing fatty acid uptake and oxidation and suppressing fatty 
acid synthesis via mechanisms involving AMPK, p38 MAPK and PPARα 
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signaling (Ceddia RB et al., 2005; Fruebis J et al., 2001).  Adiponectin also 
confers beneficial metabolic effects in muscle by enhancing mitochondrial 
biogenesis (Iwabu M et al., 2010). Indeed, an important link between 
adiponectin and activation myocyte enhancer factor 2C (MEF2C) may be 
important in the PGC1α-mediated increase in mitochondrial biogenesis as 
well as a fiber type switch, both of which will provide more oxidative 
capacity (Civitarese AE et al., 2006). 
 
Adipocyte, Inflammation, and Insulin resistance  
Adipocyte’s role in insulin resistance is broader than what it was 
initially expected. It has been well established that the adipocytes play a 
role in inflammation, because it is capable of secreting cytokines related to 
insulin resistance like tumoral necrosis factor-a (TNF-α). TNF-α interferes 
with insulin receptor signalling cascade, by the activation of kinases that 
phosphorylate serine residues in the substrate of the receptor (IRS-1 and 
IRS-2), preventing the insulin signal transfer, creating a insulin resistance 
scenario, which results in the release of lipolysis in adipocytes, generating 
more availability of FFA to the skeletal muscle; this favours insulin 
resistance as well. 
The mechanism that explains adiponectin effects in muscle, 
establishes that it activates a kinase called AMP-activated protein kinase 
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that in turn has 2 metabolic results: (1) activates glucose transport into the 
cell and (2) enhances fatty acid oxidation, all done through the activation 
AMPK (AMP activated protein kinase).  Which inhibits acetyl CoA 
carboxylase, main enzyme for lipogenesis, and which in turn lowers 
producing malonyl CoA levels within cytosol. When malonyl CoA 
decreases, this stops inhibition of carnitin–palmitoyl transferase-1 or 
carnitin transporter, which is the enzyme responsible for fatty acid 
transport from the cytosol to the mitochondria, this way this allows the 
entrance of fatty acids from cytosol to the mitochondria, fuelling the b 
oxidation (ACC, acetyl CoA carboxylase; CPT-1, carnitin–palmitoyl 
transferase-1; GLU, glucose) activating mitochondrial b oxidation (Ferre´ 
P 2004) Shown in Fig 1.3. 
 
Fig 1.3.: adiponectin has 2 main metabolic routes: activation of glucose entrance to the cell 
and enhancement of fatty b oxidation; all done through the activation AMPK (AMP activated 
protein kinase). (Valmore Bermu´ dez et al., 2010). 
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CHAPTER II 
 
OVERVIEW AND AIM OF DISSERTATION 
 
The cure of any disease depends on a fundamental understanding of 
identifying the elements involved in the initiation and progression of a 
disease. As an excellent example we show nutritional therapy to treat 
diabetes and obesity. To enhance evidence based efforts that aim to 
generate homeostasis of both energy balance and glucose metabolism.  
  The purpose of this project is to understand (i) how mitochondrial 
insufficiency induced by nutrient overload contributes to increase 
inflammatory signalling and insulin resistance in muscle cells, (ii) how 
inflammatory signalling may potentiate mitochondrial dysfunction and (iii) 
how impaired mitochondrial function and pro-inflammatory signalling 
induced by fuel oversupply can be mitigated to improve skeletal muscle 
insulin sensitivity. 
 In this study we look for insulin resistance and type 2 diabetes 
emphasizing these disorders by metabolism in mitochondria which prove 
beneficial. We assess the coupling efficiency of mitochondrial oxidative 
phosphorylation and its potential as a target for future anti-obesity 
interventions. Coupling efficiency is the proportion of oxygen 
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consumption used to make adenosine triphosphate (ATP) and do useful 
work. High coupling efficiency may lead to fat deposition; low coupling 
efficiency to a decrease in fat stores. Thus, it is logical that a deeper 
understanding of the various molecular reactions would serve to accelerate 
the efforts pertaining to the effects of different diets on mitochondrial cells. 
To facilitate development of improved glycemic properties, the research 
described herein represents only a portion of a larger scheme focused on 
generating and characterizing a series of profiles representing key stages in 
the blood parameters that occur naturally in the mouse. 
 We focused on the potential therapeutic benefit of a diet with high 
omega-3 content, with an emphasis on fish oil derived omega-3 PUFAs, in 
the regulation of skeletal muscle metabolic function with the hypothesis: 
Exposure to PUFAs from fish oil or milk interventions reduce 
mitochondrial ROS production and help lessen pro-inflammatory 
signalling and insulin resistance associated with nutrient overload. 
 
• Dietary PUFA, High Fat Diet and Inflammation  
At a cellular level, fatty acids are not only structurally important, as 
the main component of cellular membranes, but also have an important 
function in a number of metabolic processes such as regulating the activity 
of certain enzymes and by acting as signalling molecules (Burdge, G.C.; 
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Calder, P.C. 2015). Therefore, alterations in the composition of the muscle 
lipid pool may have profound effects on skeletal muscle metabolic and 
physical function. 
 Diets rich in saturated fatty acids (SFAs) have been associated with 
an increased risk for obesity, IR and the high fat diet (HFD) rich in lard 
induces obesity, inflammation and oxidative stress, on the other hand 
dietary PUFA from fish oil mainly those of the n-3 family, are known to 
play essential roles in the maintenance of energy balance and in the 
reduction of body fat deposition through the up regulation of mitochondrial 
uncoupling that is the main source of reactive oxygen species by protecting 
against the metabolic diseases (Abete I et al., 2011; Gonzalez-Periz A et 
al., 2009; Nakatani T et al., 2003; Xin YN et al., 2008) Fatty acid species 
are classified by their varying degrees of saturation into three main classes; 
saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and 
polyunsaturated fatty acids (PUFAs). SFAs are a simple carbon chain 
containing no double bonds, MUFAs contain one double bond and PUFAs 
are classified as carbon chains containing two or more double bonds. The 
differences in the chemical structure of these different classes can lead to 
different physiological effects. While the human body cannot synthesize 
omega-3 and omega-6 PUFAs, it does have the capacity to further 
metabolize these fatty acids through stages of elongation and desaturation. 
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The Omega (ω)3 PUFAs, docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA), are dietary compounds that are intensively 
studied as potent anti-inflammatory products, able to reduce the risk of 
insulin resistance and ameliorate obesity-associated disorders affecting 
hormonal control and modulating AMPK activity (Xue et al., 2012; 
Martínez-Fernández etal., 2015).  
 
 
Fig 2.1 Highlights some of the mechanisms of action by which omega-3 PUFAs EPA and 
DHA may influence skeletal muscle health and function. (Stewart Jeromson et al., 2015) 
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We hypothesized that the beneficial effects of PUFA may be mediated 
by AMPK. To this aim, rats were fed a control diet (CD), or isocaloric 
HFD containing either fish oil (FD; rich in ω3-PUFA) or lard for 6 weeks, 
and the activation of AMPK, inflammatory state (IKKβ, TNF-α) and 
oxidative stress were analyzed in the skeletal muscle. In addition, we also 
studied serum lipid profile, homeostatic model assessment (HOMA) index, 
and pro-inflammatory parameters.  
Milk:  Milk contains a number of essential nutrients. Cow milk (CM), 
the primary marketed product consumption in the first months of life has 
been suggested as a potential factor contributing to the increasing burden 
of obesity and related disorders.  
Nutritional composition of Milk can be improved by the feeding 
regime. Organic milk, from grass fed cows, has a much more favourable 
nutrient profile than milk from conventional, grain-fed cows. A diet based 
on grass results in double the omega-3 fat content with more and richer 
milk as conventional milk. Cow’s milk that's higher in an essential fatty 
acid called alpha-linolenic acid (ALA), an omega-3 fat may promote 
positive health effects on lipid metabolism, redox status, and inflammatory 
response with lower risk of heart disease, stroke and type 2 diabetes.  
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Experimental/research methods used 
This work involved extensive use of rat skeletal muscle and liver for use in 
an array of biochemical techniques that will allow us to determine 
mitochondrial respiration rates through analysis of oxygen consumption 
and expression/activation status of proteins with key roles in mitochondrial 
function, insulin and inflammatory signalling. 
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CHAPTER III 
 
POLYUNSATURATED FATTY ACIDS ATTENUATE DIET 
INDUCED OBESITY AND INSULIN RESISTANCE, 
MODULATING MITOCHONDRIAL RESPIRATORY 
UNCOUPLING IN RAT SKELETAL MUSCLE 
 
 
Objectives 
Omega (ω)-3 polyunsaturated fatty acids (PUFA) are dietary compounds 
able to attenuate insulin resistance. Anyway, the precise actions of ω-
3PUFAs in skeletal muscle are overlooked. We hypothesized that PUFAs, 
modulating mitochondrial function and efficiency, would ameliorate pro-
inflammatory and pro-oxidant signs of nutritionally induced obesity. 
 
Study Design Rats were fed a control diet (CD) or isocaloric high fat diets 
containing either ω-3 PUFA (FD) or lard (LD) for 6 weeks. 
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Introduction  
When food intake chronically exceeds metabolic needs, efficient 
metabolism causes continued energy storage and results in obesity, a 
common condition associated with diabetes, hyperlipidemia and 
inflammatory state. 
 
Although the peripheral insulin resistance is still not fully understood, 
several mechanisms have been proposed, including an increase of 
intracellular lipid metabolites, inflammation, and endoplasmic reticulum 
(ER) stress and mitochondrial dysfunction (Savage DB et al., 2007; 
Yuzefovych LV et al., 2013; Szendroedi J 2012). In particular, ER stress 
appears to act directly as a negative modulator of insulin signaling, and 
indirectly promoting lipid accumulation (Hotamisligil GS 2010; Zhang K 
et al., 2008). Activation of AMP-activated protein kinase (AMPK) protects 
against lipid-induced hepatic (Wang Y et al., 2011) and skeletal muscle 
disorders, reducing ERstress (Salvadó L et al., 2013).  
 
The beneficial effects of adiponectin, including anti-inflammatory 
and insulin-sensitizing actions, have been well established (Ye R et al., 
2013; Liu Y et al., 2014; Yamauchi T 2013). Adiponectin plays an 
important role in the pathophysiology of diabetes in obesity, at least in part 
via regulating metabolism in skeletal muscle (Liu Y et al., 2014). 
Adiponectin, as well as leptin, directly modulate fatty acid metabolism in 
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skeletal muscle by increasing fatty acid oxidation and suppressing fatty 
acid synthesis via mechanisms involving AMPK activation (Yamauchi T et 
al., 2002; Minokoshi Y et al., 2002). Adiponectin also confers beneficial 
metabolic effects in muscle by enhancing mitochondrial biogenesis (Iwabu 
M et al., 2010). 
 
 Mitochondria are at the centre of glucose and fatty acid metabolism. 
In fact, mitochondrial dysfunction, increased production of reactive 
oxygen species (ROS), and impaired mitochondrial biogenesis are 
considered the key determinants of insulin resistance and obesity 
(Yuzefovych LV et al., 2013; Szendroedi J et al., 2012). Mitochondrial 
uncoupling, which reduces the proton gradient across the mitochondrial 
inner membrane, creates a futile cycle of glucose and fatty acid oxidation 
without generating ATP (Terada H 1990; Nedergaard J et al., 2005; Si Y et 
al., 2009; Tseng YH et al., 2010) increasing lipid oxidation and reducing 
intracellular lipid content (Harper JA et al., 2001; Harper ME et al., 2008). 
Promoting inefficient metabolism, such as the generation of heat instead of 
ATP, is a potential treatment for obesity. In fact, the modulation of 
mitochondrial function and efficiency has been suggested for the 
prevention/treatment of obesity and insulin resistance (Li B et al., 2000); 
therefore, drugs or natural molecules modulating the mitochondrial 
function and efficiency may be useful in the treatment/prevention of 
obesity and insulin resistance.  
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The ω-3polyunsaturated fatty acids (PUFA), docosahexaenoic acid 
(DHA) andeicosapentaenoic acid (EPA), are dietary compounds that are 
intensively studied as potent anti-inflammatory products, able to reduce the 
risk of insulin resistance and ameliorate obesity-associated disorders 
through affecting hormonal control and modulating AMPK activity 
(Casanova E et al., 2014; Jelenik T et al., 2010).  
 
Recently, we have demonstrated that the replacement of lard, rich in 
saturated fatty acids (SFA), with fish oil(rich in ω-3PUFA)in high-fat diet 
is able to limit the development of systemic and tissue inflammation 
(Lionetti L et al., 2014). In addition, the reduction of hepatic lipid 
accumulation by PUFAs resulted by an improved mitochondrial fatty acid 
utilization associated with mitochondrial mild uncoupling, which 
counteracted the hepatocyte damage induced by long-term over feeding 
(Lionetti L et al., 2014).  
 
Skeletal muscle, the main site of insulin-mediated glucose disposal and 
triglyceride clearance, is another attractive site for altering metabolism and 
adiposity, through engineered respiratory uncoupling. In fact, skeletal 
muscle is a chief determinant resting metabolic rate, whose reduction is 
associated with weight gain (Ravussin E et al., 1988). 
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Synopsis     Here, we hypothesized that the ω-3PUFAs, showing an 
increased ability to modulate mitochondrial function and efficiency, would 
also ameliorate pro-inflammatory and pro-oxidant signs off at over 
nutrition. To test this hypothesis, rats were fed a control diet (CD) or high 
fat isocaloric diets containing either ω-3PUFA (FD) or lard (LD) for 6 
weeks. We focused on mitochondrial function, efficiency and biogenesis of 
mitochondria located beneath the sarcolemmal membrane 
(subsarcolemmal[SS]) or between the myo fibrils (intermyofibrillar [IMF]) 
in skeletal muscle. Infact, these two mitochondrial populations exhibit 
different energetic characteristics (Cogswell AM et al., 1993; Mollica MP 
et al., 2006) and therefore can be differently affected by physio-
pathological stimuli. Finally, cytoprotective enzymes activities and ER 
stress modulation by ω-3PUFAs were analyzed. 
 
Experimental procedures with animals  
Young male Wistar rats (60 days old; 345±7g; Charles River, Calco, 
Lecco, Italy) were individually caged in a temperature- controlled room 
and exposed to a daily 12h–12hlight–dark cycle with free access to chow 
diet and drinking water. Rats were divided into 3 experimental groups 
(n=8) according to a different 6 weeks dietary regimen: the first group 
(control diet, CD) received a standard diet (10.6% fat J/J); the second 
group (LD) received the high fat diet rich in lard (40% fat J/J); the third 
group (FD) received the high fat diet rich in fish oil (40% fat J/J). The 
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composition of all dietary regimens is reported in (Tables 3. 1–2). An 
additional group (n=8) was sacrificed at the beginning of the study to 
establish baseline measurements of body compositions.  
 
After 6 weeks feeding, the animals were anaesthetized by injection of 
chloral hydrate (40 mg/100 g body weight, i.p.), and blood was taken from 
both the inferior cava and portal vein. Skeletal muscle was removed; 
samples not immediately used for mitochondrial preparation were frozen 
and stored at-80°C. 
 
 
Table 3.1 Diet Composition 
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Evaluation of body composition and energy balance: 
During the experimental time, the body weight and food intake were 
monitored daily to calculate weight gain and gross energy intake. Spilled 
food and faeces were collected daily for precise food intake calculation. 
Energy balance assessments were conducted over the 6 weeks of feeding 
by the comparative carcass evaluation (Iossa et al., 2002). The gross 
energy density for the standard diet or high fat diets (15.8 or 20.0 kJ/g, 
respectively), as well as the energy density of the faeces and the carcasses, 
were determined by bomb calorimetric (Parr adiabatic calorimetric, Parr 
Instrument Co.,Moline, IL,USA). Energy, fat and protein content in animal 
carcasses were measured; according to Iossa et al. Metabolisable energy 
(ME) intake was determined by subtracting the energy measured in faeces 
and urine from the gross energy intake, which was determined from the 
daily food consumption and gross energy density. Energy efficiency was 
calculated as the percentage of body energy retained per ME intake, and 
energy expenditure was determined as the difference between ME intake 
and energy gain. 
 
Measurement of oxygen consumption (VO2), carbon dioxide 
production  
(VCO2) and respiratory quotient (RQ) Upon an adaption period to the 
experimental environment (atleast1 day), VO2 and VCO2, were recorded 
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by a monitoring system (Panlab s.r.l., Cornella, Barcelona, Spain) 
composed of a four-chambered indirect open-circuit calorimeter, designed 
for continuous and simultaneous monitoring. VO2 and VCO2 were 
measured every 15min (for 3 min) in each chamber for a total of 6 hours 
(from 8:00amto 14:00 pm). The mean VO2, VCO2 and RQ values were 
calculated by the “Metabolism H” software (Dominguez JF et al., 2009). 
 
 
Table 3.2:   Fatty acid composition (g/100g fatty acid) of experimental 
diets 
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Oral glucose tolerance test, insulin tolerance test, and serum analysis  
For the oral glucose tolerance test, overnight fasted rats received oral 
administration of glucose (3g/kg body wt) dissolved in water. For the 
insulin tolerance test, rats were fasted for 5 h and then injected intra 
peritoneally with insulin (homolog rapid-acting, 10units/kg body wt in 
sterile saline; Novartis, Basel, Switzerland). Samples of blood were 
collected before the oral glucose and insulin tolerance tests and at various 
times thereafter, and glucose and insulin values were determined by means 
of a glucose monitor (BRIO,Ascensia,NY), calibrated for use with rats and 
ELISA (Mercodia rat insulin; Mercodia, Uppsala, Sweden), respectively.  
 
Basal fasting values of serum glucose and insulin were used to 
calculate Homoeostatic Model Assessment (HOMA) index as (Glucose 
(mg/dL) Insulin (mU/L))/405 (Cacho J et al., 2008).  
 
Plasma concentrations of triglycerides and cholesterol, and non-
esterified fatty acids (NEFAs) were measured by colorimetric enzymatic 
method using commercial kits (SGM Italia, Italy and Randox Laboratories 
ltd., UnitedKingdom). Commercially available ELISA kits were used to 
determine adiponectin and leptin (B-Bridge International, Mountain 
View,CA), lipopolysaccharide (LPS) (Limus Amebocyte Lysate QCL-
1000, LonzaGroup Ltd), TNF-α and monocyte chemo attractant protein 
(MCP)-1(ThermoScientific, Rockford, IL). 
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Analysis in skeletal muscle and mitochondrial parameters  
Hindleg muscles were freed of excess fat and connective tissue, 
finely minced and washed in a medium containing 100mM KCl, 50mM 
TRIS, pH 7.5, 5mM MgCl2, 1mM EDTA, 5mM EGTA, 0.1% (w/v) fatty 
acid free bovine serum albumin (BSA). Tissue fragments were 
homogenized with the above medium (1:8, w/v) in a Potter Elvehjem 
homogenizer (Heidolph,Kelheim, Germany) setat 500 rpm (4strokes=min) 
and filtered through sterile gauze. Homogenate was then centrifuged at 
500×g for 10min and the resulting precipitate was subsequently used for 
the preparation of the IMF mitochondria. The supernatant was centrifuged 
at 3000×g for 10min and the resulting pellet, containing SS mitochondria, 
was washed twice and resuspended in suspension medium. The pellet from 
the 500×g centrifugation was resuspended in a small amount of 
homogenization solution and treated with protease nagarse (9U/g tissue) 
for 5 min. The suspension was then homogenised, filtered through sterile 
gauze and centrifuged at 3000×g for 10 min. The resulting supernatant was 
rapidly discarded and the pellet was resuspended and centrifuged at 500×g 
for 10min. The supernatant containing the IMF mitochondria was 
centrifuged at 3000×g for 10min, the pellet was washed once and 
resuspended in suspension medium. Mitochondrial oxygen consumption 
and basal/palmitate induced proton-leaks were evaluated (Iossa S et al., 
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2002). Oxygen consumption was measured polarographically with a Clark-
type electrode (Yellow Springs Instruments, Yellow Springs, Ohio) in a 3-
ml glass cell, at a temperature of 30°C. Isolated SS or IMF mitochondria 
(0.1 mg protein/ml) were incubated in a medium containing 30mM KCl, 6 
mM MgCl2, 75mM sucrose,1mM EDTA, 20mM KH2PO4 pH 7.0, and 
0.1% (w/v) fatty acid-free BSA. In the presence of 10mM succinate, 3.75 
mM rotenone and 0.6 mM ADP, state 3 oxygen consumption was 
measured. State 4 was obtained in the absence of ADP. The respiratory 
control ratio (RCR) was calculated as the ratio between states 3and 4. In 
control experiments, we assured the quality of our mitochondrial 
preparation by checking that contamination of mitochondria by other 
ATPase-containing membranes was lower than 10%, and addition of 
cytochrome c (3nmol/mg protein) only enhanced state 3 respiration by 
approximately 10%. Measurements of basal proton leak kinetics were 
performed as below reported. Mitochondrial oxygen consumption was 
measured polarographically, and membrane potential recordings were 
performed in parallel with safranin O using a Jasco dual-wave length 
spectrophotometer (511–533 nm). The absorbance readings were 
transferred to milli volt membrane potential using the Nernst equation, 
ΔC=61 mV×log([K+]in/[K+]out), and calibration curves made for each 
preparation. Measurements were carried out at 30°C in a medium 
containing 30mmol/lLiCl, 6mmol/lMgCl2, 75mmol/l sucrose, 
1mmol/lEDTA,  20mmol/l Tris-P, pH 7.0, and 0.1% (wt/vol) BSA in the 
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presence of succinate (10 mmol/l), rotenone (3.75 μmol/l), oligomycin (2 
μg/ml), safranin O (83.3 nmol/mg), and nigericin (80ng/ml). Oxygen 
consumption and membrane potential were titrated by sequential additions 
of malonate upto 5mmol/l for SS and 3 mmol/l for IMF mitochondria. 
Palmitate-induced proton leak kinetics was evaluated as above in the 
presence of palmitate (45 μmol/l and 65 μmol/l for SS and IMF 
mitochondria, respectively). Carnitine-palmitoyl-transferase (CPT) activity 
was followed spectrophotometrically as CoA-sH production by the use of 
5,5'-dithiobis (nitrobenzoic acid) (DTNB) and as substrate palmitoyl co a 
10 μM. The medium consisted of50mM KCl, 10mM Hepes(pH 7.4), 
0.025% Triton X-100, 0.3mM DTNB,  and 10–100 pg of mitochondrial 
protein in a final volume of 1.0 ml. The reaction was followed at 412nm 
with spectrophotometer, and enzyme activity was calculated from an E412 
=13,600/ (M Xcm). The temperature was thermostated to 25°C (Alexson 
SE et al., 1988). Determination of aconitase specific activity was carried 
out in a medium containing 30mM sodiumcitrate, 0.6 mM MnCl2, 0.2mM 
NADP, 50mM TRIS-HCl pH 7.4, and 2 units of isocitrate dehydrogenase. 
The formation of NADPH was followed spectrophotometrically (340nm) 
at 25°C. The level of aconitase activity measured equals active aconitase 
(basal level). Aconitase inhibited by ROS in vivo was reactivated so that 
total activity could be measured by incubating mitochondrial extracts in a 
medium containing 50mM dithiothreitol, 0.2 mMNa2S, and 0.2mM 
ferrous ammonium sulphate (Hausladen A et al., 1996). Rate of 
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mitochondrial H2O2 release was assayed by following the linear increase 
influorescence (ex 312nm and em 420nm) due to the oxidation of 
homovanillic acid in the presence of horseradish peroxidase (Barja G 
1998).  
 
Skeletal muscle lipid content was determined using Folch method 
(Folch J et al., 1957) and lipid droplets were assessed in haematoxylin-
eosinstained sections. Adipocyte differentiation-related protein (ADRP) 
expression in rat gastrocnemius was assessed immune histochemically and 
glycogen staining with periodic acid-Schiff (PAS).  
 
Oxidative stress markers (Carbonylated Proteins, PC and the 
GSH/GSSG ratio) were measured in skeletal muscle. PC concentration was 
spectrophotometrically measured in blood plasma and tissue samples, and 
total thiols (GSH+GSSG) in plasma and the GSH and GSSG 
concentrations in rat muscles were determined with the 
dithionitrobenzoicacid (DTNB) GSSG reductase recycling assay (Bergamo 
P et al., 2007).  
 
NF-E2-related factor 2(Nrf2) is considered the main mediator of 
cellular adaptation to redox stress and its translocation into the nucleus, 
upon the dissociation from the Kelch-like ECH-associated protein 1 
(Keap1), triggers the transcription of several enzymes involved in 
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detoxification and chemopreventive mechanisms (glutathione S-
transferases, GSTs; NAD(P) H:quinone oxidoreductase, NQO1; heme 
oxygenase-1). To investigate the possible involvement of NF-E2-related 
factor 2(Nrf2) in the diet-induced stress, cytoplasmic and nuclear extracts 
were prepared from rat muscle tissue ((Bergamo P et al., 2007). The 
enzymatic activities of GST and NADPH quinone oxidoreductase 
1(NQO1) were evaluated spectrophotometrically in cytoplasmic extracts 
(Benson M et al., 1980; Levine RL et al., 1990; Habig WH et al., 1981) 
and the levels of Nrf2 levels in the nucleus were immune detected by 
Western blotting analysis. 
 
For p-Akt detection in skeletal muscle, additional six rats for each 
group were feed deprived for 6h, then were administered insulin (10 U/Kg) 
and were killed 15min after insulin injection for Western blot analysis. 
 
Western blot analysis  
Skeletal muscle was homogenized and total protein lysates were 
subjected to SDS-PAGE. Blots were probed with p-Akt(Ser473) and Akt 
(Cell Signalling, MA, USA, diluted 1:1000 in blocking buffer) or TNFα, 
BiP/ glucose regulated protein (GRP)78, p-eukaryotic translation initiation 
factor (eIF)2α,t-eIF2α,p-AMPK,t-AMPK (Santa Cruz Biotechnology, 
Santa Cruz, CA,USA). Western blot for tubulin or lamin was performed to 
ensure equal sample loading. 
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Quantitative real-time PCR analysis 
 Total RNA was extracted from skeletal muscle using the TRIzol 
Reagent (Ambion). After DNase treatment (Ambion), RNA was quantified 
using a Nanodrop 2000c spectrophotometer (ThermoScientific) and 
reverse-transcribed (1 μg) using the Advantage RT-PCR kit (Clontech) and 
oligo dT primer. Universal Probe Library Assay Design Center 
(https://www.roche-applied-cience.com/sis/ 
rtpcr/upl/index.jsp?id=UP030000) was used for designing primers. The 
Real Time-PCR reactions were performed using a 7500 Real-Time PCR 
System (Applied Biosystems) in the presence of 1X Power Sybr Green 
PCR Master mix (Applied Biosystems) and 0.1 μM of each primer and 
30ng of cDNA. The thermal protocol was as follows: 2min at 50°C, 10min 
at 95°C, followed by 40 cycles of 15 sec at 95°C and 1min at 60°C. For all 
of the genes examined the reactions were conducted in technical 
duplicates. For each well, the evaluation of PCR efficiency and optimal 
threshold cycle (CT) of the target genes peroxisome proliferator-activated 
receptor γ co activator (PGC) 1α, PGC1β, fibroblast growth factor (FGF) 
and the endogenous control gene (β-actin) were performed using the 
REAL TIME PCR MINER online tool (Zhao S et al., 2005). The mean 
relative expression ratio (rER) of the target genes was calculated using β-
actin as the endogenous control gene and cDNA as the reference sample 
applying the formula:  
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rER = (1 + E target gene) -ΔCT target gene/ (1 + E endogenous control) -
ΔCT endogenous control  (Schefe JH et al., 2006), where ΔCT target gene is the 
difference between the CT value of the target gene in the skeletal muscle 
of the FD, LD rats and the CT value of the target gene in the skeletal 
muscle of the control rats, ΔCT endogenous control is the difference 
between the CT value of the β-actin gene in skeletal muscle of the FD, LD 
rats and the CT value of the β-actin gene in the skeletal muscle of the 
control rats (Schefe JH et al., 2006). 
 
Primer sequences used for Real-Time Polymerase Chain Reaction are 
the following:  
β-actin  5’-ATTGCTGACAGGATGCAGAA-3’  
5’-TAGAGCCACCAATCCACACAG-3’ 
FGF21  5’-CACACCGCAGTCCAGAAAG-3’  
   5’-GGCTTTGACACCCAGGATT-3’.  
PGC1-α  5’-AAAGGGCCAAGCAGAGAGA-3’  
5’-GTAAATCACACGGCGCTCTT-3’  
PGC1-β  5’-TTGACAGTGGAGCTTTGTGG-3’ 
5’-GGGCTTATATGGAGGTGTGG-3’ 
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Statistical analysis: 
All data are presented as means ± SEM. Differences among groups 
were compared by ANOVA followed by the Newman-Keuls test to correct 
for multiple comparisons. Differences were considered statistically 
significant at p<0.05. All analyses were performed using GraphPad Prism 
(GraphPad Software, San Diego, CA) 
 
Results: Energy balance 
 
As shown in Table 3.3, LD rats were characterized by a significant 
increase of body weight and weight gain, lipid accumulation and body 
energy levels compared to CD and FD animals; in addition, LD rats 
contained significantly lower percentages of water and protein compared to 
CD or FD rats. Despite a comparable ME intake, LD rats showed energy 
efficiency, body weight gain (expressed in g and kJ), lipid gain and lipid 
gain/ME intake values significantly higher than those of FD-fed animals. 
Decreased lipid accumulation in FD- compared to LD-fed animals was 
associated with higher energy expenditure, increased O2 consumption/CO2 
production and lower energy efficiency. Moreover, LD and FD rats 
showed a lower respiratory quotient (RQ) compared to CD rats. Therefore, 
the low lipid gain and lipid gain/ME intake of FD animals (vs LD) 
indicates an improved ability to utilize fat, as a metabolic fuel. 
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Table 3.3 Body Composition, energy balance and calorimetric 
parameters: 
 
 
 
 
 
~ 58 ~ 
 
 
Table 3.4. Blood Parameters: 
 
 
Serum metabolite levels and glucose homeostasis  
Blood parameters and hormonal determination are reported in Table 
3.4. Serum metabolic (triglycerides, cholesterol, and insulin), and pro-
inflammatory (TNFα, MCP1 and LPS) parameters in LD-fed animals were 
increased compared to those measured in rats on CD and, interestingly, no 
significant difference was shown in the same parameters between FD and 
CD. In contrast, NEFA and leptin concentrations were significantly higher 
after both high fat diet regimens compared to CD, however values from 
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LD were significantly higher than those of FD rats. In addition, 
adiponectin concentration was reduced in LD compared to CD or FD 
animals, while glucose level was significantly increased both in LD or FD. 
The HOMA-IR index was significantly greater in LD than in CD or FD-
fed animals (Fig 1A). Accordingly, FD rats exhibited a higher tolerance to 
glucose loading than LD rats; in fact, despite similar glucose levels, FD 
rats exhibited a significantly lower insulin concentration and a reduced 
insulin area under the curve (AUC) than LD rats (Fig 1Band 1C),. Insulin 
tolerance test revealed less glucose reduction, following insulin 
administration in LD and FD rats compared to control animals (Fig 1D), 
however rats on ω-3 PUFA high fat diet showed an increased reduction of 
glucose levels compared to LD, indicating that fat present in the diet (lard 
or fish oil) can differently modify glucose metabolism. In fact, even if FD 
did not improve glicemic profile HOMA and insulin secretion results in 
part recovered, suggesting that in high fat diet the substitution of lard with 
ω-3PUFA can ameliorate insulin sensitivity. Data obtained on insulin 
signal transduction on skeletal muscle support this hypothesis. We 
evaluated Akt phosphorylation in skeletal muscle by western blot analysis 
after in vivo stimulation with the hormone. Insulin-stimulated Akt 
phosphorylation was less in LD-fed rats than in FD or CD-fed animals (Fig 
1E). Significantly higher total lipid content in skeletal muscle (Fig 1F) and 
the widest glycogen-depleted areas in PAS sections were observed in LD-
fed rats (Fig 1G upper panels). LD animals also exhibited a weaker 
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immunostaining signal for ADRP in the muscle periphery and around 
adipocytesin connective tissue (Fig 1G lower panels), while it was similar 
in CD and FD. 
 
Mitochondrial function: oxidative capacity, efficiency, and oxidative 
stress 
  We found that IMF mitochondria from LD or FD-fed rats exhibited a 
significant lower State 3 respiration rate than control in presence of 
succinate, as substrate; conversely, State 3 in SS sub-population of LD-fed 
rats was less than that of FD- or CD-fed rats (Fig 2A). State 3, in presence 
of palmitoyl carnitine, was similar in IMF sub-population of LD and FD-
fed animals and significantly higher than those measured in CD rats (Fig 
2B). Conversely, in the same conditions, SS subpopulation from LD and 
FD showed a higher State 3 compared to CD-fed animals. Notably, SS 
mitochondrial sub-populations of FD exhibited a further increase in State 3 
compared to LD group, paralleled by higher levels of CPT activity; no 
significant difference was found in CPT activity in the IMF sub-population 
(Fig 2C). Proton-leakage from IMF was not influenced by the different 
diets (data not shown), and comparable basal proton-leak values were 
measured in SS mitochondria obtained from different groups (Fig 2D). 
With regard to fatty-acid-induced proton leak (measured using 
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physiological amounts of palmitate), SS mitochondria of LD rats had the 
lowest proton leak among the three groups, and FD rats had the highest 
proton leak among the three groups analyzed (Fig 2E). To compare the 
kinetic curves, oxygen consumption was also reported at a membrane 
potential of 160 mV (the highest membrane potential common to all 
obtained curves). FD-fed rats consumed more oxygen than LD- or CD-fed 
rats to maintain a given membrane potential (Fig 2E, upper insert). In IMF 
and SS mitochondrial populations, a significantly lower aconitase activity 
(Fig 2F) and a higher H2O2 yield (Fig 2G) clearly demonstrated that LD 
feeding enhanced the levels of pro-oxidant markers in muscle 
mitochondria compared to FD and CD regimens (P<0.01).  
In addition, we analyzed the expression of the FGF21, PGC1α and 
PGC1β genes. FGF21 mRNA levels in LD rats were significantly 
increased compared with CD and FD rats (Fig 2H). PGC1-α and PGC1-β 
mRNA levels significantly increased in FD compared to the other groups 
and significantly decreased in LD compared to the other groups (Fig 2I–
2L). 
The protective effects produced by FD feeding on skeletal muscle 
redox status were clearly indicated by the significant increased GSH/GSSG 
ratios respect to LD (Fig 3A upper insert). Moreover, the pro-oxidant 
effect produced by LD intake was demonstrated by a significantly lower 
GSH content (Fig 3A) and higher PC level in skeletal muscle (Fig 3B) and 
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in serum (Fig 3B upper insert); these parameters were unchanged between 
FD rats and controls (Fig 3A and 3B), confirming the beneficial effect of 
fish oil in the high fat diet. 
The negligible differences in Nrf2 protein translocation into cell 
nuclei together with comparable GST and NQO1 activities measured in 
skeletal muscle (Fig 3C) indicate that the Nrf2 pathway is not involved in 
both different high fat diet-mediated modulation of redox status. Increased 
TNFα, BiP/GRP78 and eIF2-α levels (Fig 3D–3F) were detected in the 
skeletal muscle of LD, whereas the levels in FD rats were similar to CD 
rats.  
Finally, pAMPK protein content was significantly lower in the 
skeletal muscle of LD-fed rats than in those of the other experimental 
groups (Fig 3G). LD-diet exhibited an inhibitory effect on AMPK activity, 
as indicated by a concomitant decline of ACC phosphorylation (Fig 3H), 
which is an indicator of AMPK activity (Ruderman NB et al., 1999). 
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Figure 3.1 Effect of ω-3 PUFA on glucose and lipid metabolism. HOMA-IR index (A); Plasma 
insulin (B), and glucose (C) concentrations at different time intervals after glucose load and 
respective area under curve (AUC) (upper inserts) and insulin tolerance test (D) are shown. 
Representative western blots of insulin-induced Akt phosphorylation (Ser473) (E), and lipid content 
(F)in skeletal muscle are also reported. The graphic reported in panel 1E represent the densitometric 
analysis of protein band obtained in three separate experiments. Haematoxylin-eosin sections of 
glycogen (G upper panels), ADRP expression (G lower panels) are shown. PAS positive material 
was stained magenta at a magnification of 20x. Values are expressed as means±SEM from n = 8 
animals/group. Different superscripted letters indicate statistically significant differences (P<0.05). 
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Figure 3.2 Effect of ω-3 PUFA on mitochondrial functions and energy efficiency. IMF and SS 
mitochondrial respiration in the presence of succinate (A) or palmitoyl-carnitine (B) as substrates 
were determined. CPT activity (C); basal (D) or palmitate-induced (E) proton leakage in SS 
mitochondria and respiration rates at 160 mV (the highest membrane potential common to all the 
curves) (upper insert); aconitase activity (F); H2O2 yield (G), relative mRNA expression of FGF21 
(H), PGC1α (I), PGC1β (L) are also shown. Values are expressed as means±SEM from n = 8 
animals/group. Different superscripted letters indicate statistically significant differences (P<0.05). 
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Figure 3.3 Effect of ω-3 PUFA on oxidative- and ER-stress and AMPK activation. Total thiols 
(A) and GSH/GSSG ratio (upper insert); protein carbonyl levels in skeletal muscle (B) and in serum 
(upper insert). Cytoplasmic GST and NQO1 activities and Nrf2 levels in nucleus (C). 
Representative immunoblots of TNFα (D) and BiP/GRP78 (E) p-eIF2-α (F), pAMPK (G) and 
pACC (H) are shown. Densitometric analysis of protein bands are reported: after normalization 
Fatty Acid and Skeletal Muscle Metabolism the levels are expressed as the density ratio of target to 
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control (tubulin, lamin or total protein). Values are expressed as means±SEM from n = 8 animals/ 
group. Different superscripted letters indicate statistically significant differences (P<0.05). 
 
Discussion 
The main finding of this study is that the intake of ω-3 PUFAs 
enriched diet, at high percentage, reduces fat accumulation in skeletal 
muscle and decreases metabolic/mitochondrial efficiency, attenuating 
insulin resistance, ER- and oxidative-stress, compared to an isocaloric high 
fat diet rich in SFAs. Moreover, SS mitochondria were identified as the 
main target of diet induced alterations in function and efficiency. The 
effects exerted by ω-3 PUFAs intake (Holness MJ et al., 2005; Lanza IR et 
al., 2013) have been associated to mitochondrial uncoupling and 
AMPK/ACC, rather than to Nrf2 pathway activation in skeletal muscle. 
Here, LD-feeding was associated with high metabolic efficiency, 
weight gain, body lipid levels, and also with metabolic alterations, such as 
dyslipidemia, and insulin resistance, accompanied by an increase in low 
grade inflammation compared to a standard diet. As reported, despite 
comparable ME intake between LD and FD groups, the substitution in 
lard-based diet with ω-3 PUFA in high fat fed animals showed a reduction 
in metabolic efficiency, body weight and body lipid levels, accordingly 
with a correction of dyslipidemia and insulin resistance. These data are 
consistent with previous findings, indicating a reversal of insulin resistance 
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by ω-3 PUFA intake. The effects on body weight and lipids, we observed 
in FD-fed rats, can be explained, at least in part, by an increase in energy 
expenditure/O2 consumption and reduced energy efficiency. Moreover, the 
decreased RQ index observed in LD and FD-fed animals, which reflects 
the ratio of carbohydrate to fatty acid oxidation, demonstrates that these 
animals used a higher amount of fatty acids, as a fuel source, compared to 
controls. These data indicate that FD intake improves the ability to utilize 
fat, as a metabolic fuel, which suggests that the large part of the higher 
energy intake was dissipated through increased metabolic activity in these 
animals. 
An interesting finding is that high-fish oil diet despite to any effect 
on glycaemia in confront of LD, it is able to attenuate the development of 
insulin resistance, preventing the alteration of glucose tolerance related to 
an impairment of insulin signalling due to fat over nutrition. The 
improvement in insulin sensitivity may be, at least in part, a consequence 
of the anti-inflammatory effect of ω-3 PUFAs in this nutritional model. 
Our previous study showed that high-fish oil diet attenuated the 
development of systemic and tissue inflammation (Lionetti L et al., 2014) 
and decreased hepatic lipid accumulation through improved mitochondrial 
fatty acid utilization supported by mitochondrial uncoupling (Lionetti L et 
al., 2014). 
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Here, HOMA index and oral glucose and insulin tolerance tests 
showed that high-fish oil diet attenuated alteration of glucose homeostasis 
compared to an isocaloric lard-based diet, indicating that fat present in the 
diet (lard or fish oil) can differently modify insulin sensitivity. 
Consistently, at skeletal muscle level, FD also attenuated tissue insulin 
resistance, modulating insulin signaling, restoring protein kinase B 
(PKB/Akt) phosphorylation and decreased lipid accumulation, increasing 
ADRP levels, involved in the proper TG storage (Bosma M et al., 2012) 
and AMPK activation. All these metabolic effects of fish oil fat diet are 
strengthened by the suppression of inflammatory process, evidenced by 
reduced serum levels of TNFα, MCP-1 and LPS, and of ER stress at 
skeletal muscle level, where GRP78 expression and eif2α activation were 
down-regulated. 
The effects of ω-3 PUFA overload on the prevention of weight gain 
excess and the development of insulin resistance may be mediated by 
adiponectin and leptin, two adipokines that regulate glucose and lipid 
metabolism, through AMPK activation (Yamauchi T et al., 2002; 
Minokoshi Y et al., 2002). Our results demonstrate decreased serum leptin 
levels in FD, consistently with fat mass reduction, compared to LD rats, 
and restored serum adiponectin levels to those of CD rats, suggesting a key 
role of fish oil in the reduction of the development of insulin resistance in 
an animal model of fat over nutrition. The reduced adiponectin values 
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found in LD rats were consistent with those reported by (Kalupahana et al., 
2010) It is well known the lipid sensor activity of AMPK, an important 
metabolic regulator (Long YC et al., 2006). Notably, the activation of 
AMPK exhibits multiple protective effects, including a reduction in 
inflammation, oxidative stress and insulin resistance (Long YC et al., 
2006). Recently it has been reported that AMPK activation protects against 
lipid-induced disorders (Wang Y et al., 2011; Salvadó L et al., 2013) by 
reducing ER stress. Previous findings by Jelenik et al. (Jelenik et al., 2010) 
showed that ω-3 PUFAs intake induced AMPK activation in liver, 
reverting insulin resistance and steatosis in mice. 
      Here, we found that FD, in a different way by LD, modulated 
AMPK/ACC pathway restoring adiponectin and fatty acid metabolism in 
skeletal muscle. Skeletal muscle is the primary tissue involved in the 
regulation of glucose metabolism, energy expenditure and lipid utilization 
and it is inherently linked to the development of whole-body insulin 
resistance (Stannard SR et al., 2004). The recognized link between insulin 
resistance and mitochondrial dysfunction prompted us to evaluate the 
effect of dietary fat regimens on mitochondrial oxidative capacity, energy 
efficiency, and oxidative stress in both SS and IMF mitochondrial 
populations. Indeed, SS mitochondria provide energy for membrane-
related processes, such as substrate oxidation and insulin action, whereas 
IMF mitochondria support muscle contraction (van Loon LJ et al., 2004). 
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In addition, SS mitochondria may be more susceptible to damage by 
ectopic lipid deposition, because lipid content decreases exponentially 
from immediately below the sarcolemma toward the central region of the 
muscle fiber (Nielsen J et al., 2010). Because of their proximity to the 
sarcolemmal membrane, SS mitochondria can more easily interfere with 
key proteins involved in the insulin-signalling cascade (Nielsen J et al., 
2010), anyway a pivotal role in insulin-mediated glucose transporter 
trafficking has been shown also for t-tubules structure (Lauritzen HP 
2013). Interestingly, we demonstrate that both fat diets mainly affect SS, 
rather than IMF mitochondria, indicating that the observed mitochondrial 
alterations may contribute to the pathogenesis of insulin resistance. In 
particular, no difference was observed in IMF mitochondria uncoupling, 
while SS subpopulation demonstrated an increased uncoupling in FD fed 
rats. Association between diet-induced ectopic fat storage in skeletal 
muscle and mitochondrial dysfunction (Szendroedi J et al., 2012; 
Crescenzo R et al., 2006) is well known. Accordingly, LD-rat skeletal 
muscle mitochondria exhibited reduced respiratory capacity, as indicated 
by the decrease in succinate State 3 oxygen consumption, and increased 
oxidative stress, even when the ability to utilize fat as a metabolic fuel was 
elevated. The increased mitochondrial fatty acid oxidation could be a result 
of a diet-induced increase of FFA uptake and/or enhanced CPT activity 
which would further increase the entry of long-chain FFA into the 
mitochondria. However, as such increased lipid oxidation is likely not 
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sufficient to handle the greater FFAs load, resulting in the ectopic 
triglyceride storage in skeletal muscle. Moreover, a further mechanism 
contributing to fat accumulation can be the increase in mitochondrial 
efficiency, as shown by the decrease in the induced proton leak in LD rats. 
Therefore, a higher mitochondrial efficiency, suggestive of a reduced 
amount of substrate to be burned to obtain ATP, together with an increase 
in NEFA serum levels could account for the triglyceride accumulation in 
skeletal muscle. 
In our experimental conditions, mitochondrial dysfunction in LD rats 
was related to an increase in FGF21 gene expression in skeletal muscle, 
which follows a stress response (Keipert S et al., 2014). Increased 
mitochondrial oxidative stress parameters were found in LD rats as showed 
by hydrogen peroxide yield, aconitase activity, protein carbonyls amount 
and GSH/GSSG ratio. 
This effect can be attributable to the concomitant increase in fatty 
acid oxidation rate, resulting in NADH and FADH2 generation and thus 
electron delivery to the respiratory chain, and to respiratory chain 
impairment (as indicated by the decrease in succinate State 3 oxygen 
consumption, which would partially block electron flow within the 
respiratory chain). Further, the decreased proton leak can contribute to 
excessive ROS formation (Skulachev VP 1991) in LD rats. In fact, one of 
the postulated roles of uncoupling is known to be the maintenance of 
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mitochondrial membrane potential below the critical threshold for ROS 
production (Korshunov SS et al., 1997) 
The improvement of respiratory capacity, fatty acid oxidation, CPT 
activity and the decreased mitochondrial efficiency, exhibited by the FD 
rats, may be interpreted as the result of converging protective mechanisms 
against insulin resistance. In addition, the significant alteration of all the 
considered oxidative stress markers mirrors the differential ability of ω-3 
PUFA- and SFA-based diets to trigger oxidative stress in skeletal muscle 
(Lanza IR et al., 2013). In addition, in FD-fed animals the increased 
respiratory capacity is associated with the increase in gene expression 
levels of FGF-21, PGC-1α and PGC-1β, involved not only in the 
regulation of mitochondrial activities and biogenesis (Arany Z et al., 2007; 
Lin J et al., 2002; Meirhaeghe A et al., 2003; Puigserver P et al., 1998), but 
also to the development of insulin resistance in skeletal muscle (Holloway 
GP et al., 2008). The increase in mitochondrial biogenesis was supported 
by changes in mitochondrial protein mass calculated by two different 
approaches, namely 1) by measuring the activity of a mitochondrial marker 
enzyme citrate synthase in skeletal muscle homogenates and in isolated SS 
and IMF mitochondria and 2) by evaluating the mitochondrial yield (i.e., 
milligrams isolated protein per gram starting wet tissue) in each 
mitochondrial subpopulation. Independent of the methodology applied, we 
found that the mitochondrial mass was significantly increased in both SS 
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and IMF compartments in FD rats and significantly reduced in LD rats. 
Therefore, ω-3 PUFAs, in addition to their positive effect on mitochondrial 
respiration, also act on the level of mitochondrial gene expression in 
skeletal muscle cells: the increase in PGC-1α should play a role in the 
recovery of mitochondrial respiration, promoting both oxidative 
phosphorylation-linked and uncoupling-linked respiration in differentiated 
myotubes oxidative capacity in skeletal muscle cells (Barbosa MR et al., 
2013; Wu Z et al., 1999; Zechner C et al., 2010). 
 Conversely, the negligible alteration of Nrf2-pathway, which plays a 
key role in cellular protection against oxidative stress, is consistent with 
evidence demonstrating that transient and low-levels of ROS are needed 
for Nrf2-antioxidant responsive element pathway activation (Gloire G et 
al., 2006). 
In conclusion, our data strengthened the capability of high dietary 
PUFA intake to reduce fat mass and insulin resistance associated to fat 
over nutrition, modulating energy efficiency. In particular, at skeletal 
muscle level, ω-3 PUFAs enriched diet promotes inefficient metabolism, 
generating heat instead of ATP, increases lipid oxidation, activating the 
pathway AMPK/ACC, and reduces ROS generation in mitochondria. 
Therefore, modulating mitochondrial function and efficiency in the skeletal 
muscle, they lessen pro-inflammatory, pro-oxidant signs and insulin 
resistance also in condition of nutritionally-induced obesity. 
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CHAPTER IV 
 
 
MILK FROM COW FED WITH HIGH 
FORAGE/CONCENTRATE RATIO DIET IMPROVES 
INFLAMMATORY STATE, OXIDATIVE STRESS AND 
MITOCHONDRIAL FUNCTION IN RATS 
 
 
 
Abstract 
 
Excessive energy intake may evoke complex biochemical processes 
characterized by inflammation, oxidative stress, and impairment of 
mitochondrial function that represent the main factors underlying 
noncommunicable diseases. Because cow milk is widely used for human 
nutrition and in food industry processing, the nutritional quality of milk is 
of special interest with respect to human health. In our study, we analyzed 
milk produced by dairy cows fed a diet characterized by a high forage: 
concentrate ratio (high forage milk, HFM). In view of the low n -6: n-3 
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ratio and high content of conjugated linoleic acid of HFM, we studied the 
effects of this milk on lipid metabolism, inflammation, mitochondrial 
function, and oxidative stress in a rat model. To this end, we supplemented 
for 4 wk the diet of male Wistar rats with HFM and with an isocaloric 
amount (82 kJ, 22 mL/d) of milk obtained from cows fed a diet with low 
forage: concentrate ratio, and analyzed the metabolic parameters of the 
animals. Our results indicate that HFM may positively affect lipid 
metabolism, leptin: adiponectin ratio, inflammation, mitochondrial 
function, and oxidative stress, providing the first evidence of the beneficial 
effects of HFM on rat metabolism. 
 
Introduction 
Recently, awareness of the importance of diet to human health has 
increased. Excessive energy intake, and particularly the excess or 
inadequate processing of fat in the body, may lead to activation of complex 
biochemical processes such as inflammation, oxidative stress, and 
impairment of mitochondrial function (Hernandez-Aguilera et al., 2013). 
These processes are the main factors that underlie aging and 
noncommunicable diseases, the main types of which are cardiovascular 
and chronic respiratory diseases, cancers, and diabetes. Indeed, an 
unhealthy diet often leads to obesity and metabolic disturbances, which 
have become a serious public health issue worldwide. In this regard, it 
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bears emphasizing that understanding the cellular and molecular 
mechanisms underlying these metabolic diseases is a crucial step in their 
prevention and treatment.   
Mitochondria, the primary cellular energy-generating system, are 
known to synthesize key molecules during inflammation and oxidation and 
thereby serve as the main source of free radicals. Therefore, it is no 
surprise that mitochondrial dysfunctions are associated with inflammation 
and other energy-dependent disturbances where cellular oxidative damage 
is caused by the generation of reactive oxygen species (ROS) exceeding 
the natural antioxidant activity (Chan, 2006). A growing body of evidence 
has suggested that a low-grade, chronic inflammatory state may be linked 
to obesity and its comorbidities, as well as to noncommunicable diseases 
(Hernandez-Aguilera et al., 2013). It is important to underline that the 
metabolic changes induced by inflammation include alterations in 
mitochondrial function. Therefore, mitochondrial dysfunction can be both 
the cause and consequence of inflammatory processes and elicit metabolic 
adaptations that might be either protective or become progressively 
detrimental (Currais, 2015). 
Various nutritional components are known to modulate the 
inflammatory state, mitochondrial function, and ROS production, thus 
influencing metabolic homeostasis. To prevent or limit metabolic 
disorders, special attention should be paid to the choice of appropriate 
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nutritional strategies. The fatty acid profile, in particular the content of the 
essential fatty acids n-3 and n-6, is considered an important parameter to 
determine the nutritional value of food (Daley et al., 2010). These 2 classes 
of essential fatty acids, not interconvertible, are metabolically and 
functionally distinct and often have different physiological functions (i.e., 
pro- and anti-inflammatory activity for n-6 and n-3, respectively). In 
particular, a low n -6: n-3 ratio, ranging from 2 to 4, is considered optimal 
for human health (Simopoulos, 2002). Recent studies have shown that diet 
is the decisive factor determining the fatty acid profile of cow milk (Sterk 
et al., 2011); for instance, a high forage: concentrate ratio (F:C) results in a 
milk with low n -6: n -3 ratio.  
 The conjugated linoleic acids are a group of healthy fatty acids. They 
are positional and geometric isomers derived from octadecadienoic acid, 
whose content is high in milk fat, and the CLA have been suggested to 
have immunomodulating, anticarcinogenic, and antiatherosclerosis 
properties (Dilzer and Park, 2012). The major isomer of CLA, cis-9,trans-
11 (rumenic acid), represents up to 80% of total CLA in food. Ruminant 
CLA comes from 2 sources: (1) rumen biohydrogenation and (2) 
endogenous synthesis in the mammary gland and adipose tissue by the 
activity of stearoyl- CoA desaturase on trans-11 18:1, the 
biohydrogenation intermediate of several 18-carbon UFA (Shingfield et 
al., 2010). The CLA level in the milk from different ruminant species is 
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significantly increased when animals are fed with fresh forage (Jahreis et 
al., 1997; Kelly et al., 1998; Griinari and Bauman, 1999; Tudisco et al., 
2010, 2012, 2014). 
 Based on this data, some Italian breeders are feeding dairy cows with 
a high F:C (70:30), which is different from that used in intensive farms 
(which range from 55:45 to 35:65). By feeding animals a diet with high 
F:C, milk with a low n -6: n -3 ratio and high CLA level was obtained to 
satisfy consumer demand for healthy foods (Rubino, 2014). 
 Several studies have indicated that administration of CLA and n-3 
fatty acids to rats improves fatty acid oxidation and decreases 
inflammation and oxidative stress through the modulation of mitochondrial 
function (Lionetti et al., 2014; Mollica et al., 2014; Cavaliere et al., 2016). 
We hypothesized that milk from cows fed a high-forage diet (hereafter, 
high forage milk, HFM), by modulating mitochondrial function, and 
would ameliorate the inflammatory state and oxidative stress in consumers. 
To test this hypothesis, we evaluated, in a rat model, the effects of HFM 
administration on energy balance, lipid metabolism, and anti-inflammatory 
and antioxidant defenses, compared with those rats fed isoenergetic 
amounts of milk obtained from cows fed with a diet with a low F: C ratio 
(low forage milk, LFM). 
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MATERIALS AND METHODS 
Cow feeding 
Milk was obtained from a farm located in a hilly area of central Italy 
(Segni, Rome, Italy; 13°0’E, 41°41’N, 668 m above sea level). The farm 
produced 2 types of commercial milk (LFM and HFM) from Italian 
Friesian cows (~40 animals for each type of milk) fed 2 different diets 
(lower or higher F:C ratio, respectively).  
 
Table 4.1. Energy intake via chow and milk (kJ; % of total in parentheses) 
of rats fed with milk from cows consuming a low forage (LFM) or high 
forage (HFM) diet 
Energy intake Control LFM- treated HFM-treated 
Total Energy (KJ) 11,899 13,975 14010 
Chow (KJ) 11,899 11,968 (85.64) 12,003 (85.67) 
Milk (KJ)  2,007 (14.36) 2,007 (14.33) 
 
Ingredients, F:C ratio, chemical composition, and nutritive value of the 2 
cow diets as well as feed intake are reported in Table 4.2. 
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Table 4.2. Diets fed to cows1  
 
 
Rat Handling and Feeding 
Male Wistar rats (Charles River, Calco, Lecco, Italy) were 
individually caged in a temperature controlled room and exposed to a daily 
12h–12h light–dark cycle with free access to chow and drinking water. 
Young animals (60 days old; about 350 g of BW) were used; one group 
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(n=7) was killed at the beginning of the study to establish baseline 
measurements. The remaining rats, fed with a standard diet, were divided 
into 3 experimental groups (n=7 each): 2 groups were supplemented with 
equicaloric intakes (82 kJ) of LFM or HFM (22 mL/d) for 4 wk; the group 
that did not receive milk supplement was used as control (the energetic 
intake of diets is reported in Table 4. 1). After 4 wk, the animals were 
anaesthetized by intra-peritoneal injection of chloral hydrate (40 mg/100 g 
of BW), and blood was taken from the inferior cava. The liver was 
removed and sub-divided; samples not immediately used for mitochondrial 
preparation were frozen and stored at -80°C. All experiments were 
conducted in compliance with Italian guidelines for the care and use of 
research animals.  
 
Analysis of milk composition 
Samples of milk (LFM and HFM) were analyzed for protein, fat, and 
lactose contents by the infrared method using a MilkoScan 133B 
(Fossomatic, Hillerod, Denmark). In addition, total fat of milk samples was 
separated using a mixture of hexane: isopropane (3:2, vol/vol; Tudisco et 
al., 2010). Transmethylation of fatty acids was conducted by a base-
catalyzed procedure. Fatty acid methyl esters were quantified using a GC 
(ThermoQuest 8000TOP gas chromatograph, equipped with flame-
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ionization detector; ThermoElectron Corp., Rodano, Milan, Italy) equipped 
with a CP-SIL 88 fused-silica capillary column [100 m × 0.25 mm 
(internal diameter) with 0.2-μm film thickness; Varian, Walnut Creek, CA; 
Shingfield et al., 2003]. The GC conditions were set as follows: initial 
oven temperature maintained at 70°C for 4 min, increased at 13°C/min to 
175°C and maintained for 27 min, increased to 215°C at 3°C/min and 
maintained for 38 min, before reverting to 70°C at 10°C/min. Inlet and 
detector temperatures were 250 and 260°C, respectively. The split ratio 
was 100:1, the helium carrier gas flow rate was 1 mL/min, the hydrogen 
flow to the detector was 30 mL/min, airflow was 350 mL/min, and the 
flow of helium make-up gas was 45 mL/min. Fatty acid peaks were 
identified using pure standards from Sigma-Aldrich (St. Louis, MO) except 
CLA cis-9,trans-11 methyl ester, CLA trans-10,cis-12 methyl ester, 
methyl cis-9,cis-11 octadecadienoate, and methyl trans-9,trans-11 
octadecadienoate, which were from Larodan Fine Chemicals AB (Malmo, 
Sweden). Fatty acids in samples were identified by comparing the retention 
times of peaks with that of the standard mixture. 
Body Composition, Energy Balance, and Liver Lipid Content 
 
During treatments, BW and food intake were monitored daily to calculate 
weight gain and gross energy intake. Spilled food and feces were collected 
daily for precise calculation of food intake. Energy balance assessments 
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were conducted over 4 wk of treatment by comparative carcass evaluation 
(Iossa et al., 2002). Metabolisable energy intake was assessed by 
subtracting the energy measured in feces and urine from gross energy 
intake, which was determined from the daily food consumption and gross 
energy density. The gross energy density for the standard diet (15.8 kJ/g), 
and LFM and HFM (2.70 kJ/g) as well as the energy density of the feces 
and the carcasses were determined by bomb calorimetry (adiabatic 
calorimeter, Parr Instrument Co., Moline, IL). Evaluation of the energy, 
fat, and protein content in animal carcasses was conducted according to a 
published protocol (Iossa et al., 2002). Energy efficiency was calculated as 
the percentage of body energy retained per ME intake, and energy 
expenditure was determined as the difference between ME intake and 
energy gain. Total hepatic lipid content was estimated by using the Folch 
method (Folch et al., 1957). 
 
Oral Glucose Tolerance Test and Insulin Tolerance Test 
 
For the oral glucose tolerance test, rats were fasted overnight and then 
orally dosed with glucose (3g/kg of BW) dissolved in water. For the 
insulin tolerance test, rats were fasted for 5 h and then injected 
intraperitoneally with insulin (rapid acting homolog, 10 units/kg of BW in 
sterile saline; Novartis, Basel, Switzerland). Blood was collected before 
the oral glucose and insulin tolerance tests and at various times thereafter, 
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and glucose and insulin levels were determined using glucose monitor 
(BRIO, Ascensia, NY) calibrated for rats, and ELISA (rat insulin; 
Mercodia, Uppsala, Sweden), respectively. Basal fasting values of serum 
glucose and insulin were used to calculate Homoeostatic Model 
Assessment (HOMA) index as follows: [glucose (mg/ dL) × insulin 
(mU/L)]/405. 
 
Mitochondrial Parameters 
Mitochondrial isolation, oxygen consumption, and proton leakage 
measurements were performed as previously reported (Mollica et al., 
2014). Oxygen consumption (polarographically measured using a Clark-
type electrode) was measured in the presence of substrates and ADP (state 
3) or with substrates alone (state 4), and their ratio (respiratory control 
ratio) was calculated. The rate of mitochondrial fatty acid oxidation was 
assessed in the presence of palmitoyl-l-carnitine. Mitochondrial proton 
leakage was assessed by a titration of the steady-state respiration rate as a 
function of the mitochondrial membrane potential in liver mitochondria. 
This titration curve is an indirect measurement of proton leakage because 
the steady-state oxygen consumption rate (i.e., proton efflux rate) in 
nonphosphorylating mitochondria is equivalent to the proton influx rate 
due to proton leakage. Carnitinepalmitoyl- transferase (CPT) system and 
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aconitase and superoxide dismutase (SOD) specific activities were  
measured spectrophotometrically (Flohe and Otting, 1984; Mollica et al., 
2014). Rate of mitochondrial H2O2 release was assayed by following the 
linear increase in fluorescence caused by the oxidation of homovanillic 
acid in the presence of horseradish peroxidase (Barja, 1998). 
 
Statistical Analyses 
Data were presented as the means ± standard errors. Differences among 
groups were compared by ANOVA followed by the Newman-Keuls post-
hoc test. Differences were considered statistically significant at P<0.05. 
Analyses were performed using GraphPad Prism software (GraphPad 
Software, San Diego, CA). 
 
 
RESULTS 
Milk composition 
Milk protein, fat and lactose were not significantly affected by cow dietary 
treatment (Table 4.3). Regarding the fatty acid profile of milk (Table 4.4), 
no difference was seen in SFA and MUFA content, whereas C18: 3n -3 
(linolenic acid was significantly higher in HFM than in LFM (1.117 vs. 
0.23%; P < 0.05) as were total n-3 fatty acids (1.212 vs. 0.317%; P < 0.05) 
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and PUFA (3.615 vs. 2.554%; P < 0.05). In addition, the n -6: n -3 ratio 
was significantly lower in HFM than in LFM (1.98 vs. 6.96%; P < 0.05). 
In contrast, total CLA and cis-9,trans-11 CLA were significantly higher in 
HFM than in LFM (0.79 vs. 0.45% and 0.73 vs. 0.41%, respectively; P < 
0.05). 
 
Table 4.3. Chemical composition of milks from cows consuming a low 
forage (LFM) or high forage (HFM) diet. 
 
Item LFM HFM 
Protein (%) 3.3 3.3 
Fat (%) 3.5 3.7 
Lactose (%) 4.8 4.7 
 
Body Composition and Energy Balance 
As shown in Figure 1, we observed no differences in body composition or 
energy balance between the LFM and HFM groups. In detail, LFM- and 
HFM-treated rats exhibited a diminished body water percentage (Figure 
1A) and increased body lipids percentage (Figure 1B) and body energy 
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(Figure 1C) compared with controls. No difference in body protein content 
was observed in the 3 groups of rats (Figure 1D). The LFM-treated animals 
had increased hepatic lipid content compared with the other 2 groups 
(Figure 1E). The 2 milk treatments provided similar ME intake, which was 
significantly higher than that of controls (Figure 1F). The LFM and HFM-
treated animals exhibited higher BW, body lipids, and body protein gains 
compared with control (Figure 1G-I), whereas no difference in energy 
expenditure was observed in the 3 groups (Figure 1L). Finally, gross 
energy efficiency was significantly increased in LFM and HFM groups 
compared with controls (Figure 1M). 
 
Serum Metabolites and Inflammatory Parameters 
Glucose, insulin, triglycerides, cholesterol, alanine aminotransferase, and 
IL-6 serum levels and HOMA index were not significantly different in the 
3 groups of animals (data not shown), indicating that these parameters 
were not affected by LFM or HFM administration. Confirming the HOMA 
index results, we did not observe any variation in oral glucose tolerance 
test or insulin tolerance test (Figure 2G–I). Leptin significantly increased 
in the LFM and HFM groups compared with control (Figure 2A), whereas 
adiponectin significantly was decreased in LFM compared with the other 2 
groups, and the highest level was found in HFM rats (Figure 2B). 
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Accordingly, the leptin: adiponectin ratio significantly increased in LFM 
compared with the other 2 groups (Figure 2C). Interestingly, levels of 
tumor necrosis factor-α (TNF-α) and IL-1 were significantly decreased in 
HFM-fed rats compared with controls and LFM-fed rats (Figure 2D, E), 
indicating a possible anti-inflammatory role of HFM. This hypothesis was 
further supported by the fact that IL-10, an anti-inflammatory cytokine, 
was found to increase 2-fold in the LFM group and 2.5-fold in the HFM 
group compared with controls (Figure 2F). 
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Table 4.3. Fatty acid profile (%; means ± SE) of milk from cows 
consuming a low forage (LFM) or high forage (HFM) diet 
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Mitochondrial Efficiency and Oxidative Stress 
Mitochondrial state 3 and state 4 respiration, evaluated using succinate and 
palmitoyl-carnitine as substrates, respectively (to detect fatty acid 
oxidation, was increased in LFM- and HFM-fed rats compared with the 
control (Figure 3A, B). Activity of CPT was increased in HFM-fed animals 
compared with the other 2 groups (Figure 3C). The high quality of 
mitochondrial preparations was tested by evaluation of respiratory control 
ratio values (data not shown). Mitochondrial basal and fatty acid–induced 
proton leakage was increased in LFM- and HFM-treated rats compared 
with the controls (Figure 3D, E). Finally, the beneficial effects produced 
by the HFM supplement on liver redox status were clearly indicated by the 
marked decline in the H2O2 yield and the significantly increased aconitase 
and SOD activities (Figure 3F–H). 
 
DISCUSSION 
In this study, we analyzed the fatty acid profiles of LFM and HFM and 
surveyed how the differences in milk composition affected metabolic 
parameters of rats fed with the different milks. Milk from cows fed the 
higher F:C ratio (HFM) had a higher, albeit not significant, fat percentage. 
Digestion of fiber in the rumen produces 2 lipogenic VFA—acetate and 
butyrate. Butyrate provides energy for the rumen wall, and much of it is 
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converted to BHB in the rumen wall tissue. About half of the fat in milk is 
synthesized in the udder from acetate and BHB. The other half is 
transported from the pool of fatty acids circulating in the blood. These can 
originate from body fat mobilization, absorption from the diet, or from fats 
metabolized in the liver. 
 α-Linolenic acid (C18: 3n -3), total n-3, and CLA were higher in 
HFM than LFM, confirming previous findings with milk from cows 
receiving a significant portion of daily DM from pasture and conserved 
forage-based feeds (Griinari and Bauman, 1999). Fresh forage contains a 
high percentage of UFA, with α-linolenic acid (C18:3) being the 
predominant n-3 fatty acid (Bergamo et al., 2003). Griinari and Bauman 
(1999) noted that grazing pasture is a good way of increasing the level of 
milk PUFA. In our study, C18: 3n -3 was higher in HFM, probably 
because of the higher content of this acid in the cow diet (higher F:C ratio), 
as suggested by the results obtained in milk from cows (Kelly et al., 1998) 
and dairy goats (Tsiplakou et al., 2010). Dietary treatment affects milk 
content of cis-9,trans-11 CLA and total CLA (ƩCLA), according to 
previous findings in goats and sheep (Tsiplakou et al., 2010). The higher 
concentration of milk CLA found in HFM could be due to the different 
type of diet, which may influence the rate of microbial fermentation in a 
way that alters the rate of CLA production or utilization by rumen 
microbes and, therefore, the concentration of CLA in milk fat (Kelly et al., 
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1998). Indeed, the higher levels of linoleic and α-linolenic acid—the main 
precursors of cis-9,trans-11 CLA—in the forage could explain the higher 
CLA content in HFM. 
 We hypothesized that the different compositions of LFM and HFM 
may affect metabolic parameters in the rats. One of our main findings was 
that the intake of HFM is able to reduce oxidative stress and serum pro-
inflammatory cytokines and to increase oxidation of fatty acids in hepatic 
mitochondria, which eventually reduces fat liver. 
 Our experiments allowed a comparison of nutritional, 
immunomodulatory and antioxidant effects of isoenergetic 
supplementation with 2 types of cow milk, HFM and LFM. No difference 
between the HFM and LFM groups was observed in body composition, 
energy balance, triglycerides, cholesterol, or alanine aminotransferase 
levels, or in parameters related to glucose homeostasis. Both groups 
showed an increase in ME intake and BW gain compared with control rats. 
The enhanced energy efficiency of LFM- and HFM-fed animals was 
associated with higher BW and lipid gain compared with control rats. 
Consistent with increased body lipid level, LFM and HFM groups showed 
increased levels of leptin compared with controls, and LFM also resulted 
in a decreased adiponectin level. Surprisingly, the adiponectin level 
significantly increased in HFM fed rats. Leptin and adiponectin are 
hormones derived from fat cells that are secreted into the serum, but the 
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leptin level increases with accumulation of fatty mass, whereas adiponectin 
level decreases (Oda et al., 2008). In some animal models, a decrease in 
adiponectin level occurred in parallel to decreased insulin sensitivity and 
preceding the onset of type 2 diabetes (Chakraborti, 2015). Adiponectin 
secretion is inhibited by several factors, including high level of TNF-α and 
oxidative stress (Chakraborti, 2015). Therefore, our data, showing an 
increased adiponectin level in the HFM group associated with decreased 
levels of TNF-α and H2O2, may indicate a lower inflammatory state in 
these animals. It has been proposed that a useful index of metabolic 
diseases is the leptin: adiponectin ratio, which is better correlated with 
insulin resistance than the level of leptin or adiponectin alone (Oda, et al. 
2008). Our data indicate a significantly higher leptin: adiponectin ratio in 
LFM than in the control and HFM groups, although LFM animals did not 
show changes in insulin sensitivity. Further studies, using different 
amounts of milk and administration times, will be required to fully 
investigate the possible variation of insulin sensitivity in LFM. 
 The diminished inflammatory state with HFM administration was 
confirmed by lower levels of TNF-α and IL-1 and an increased level of IL-
10 in HFM-fed animals compared with the other 2 groups. Both TNF-α 
and IL-1 are pro-inflammatory cytokines involved in the progression of 
metabolic diseases. Conversely, IL-10 is a potent anti-inflammatory 
cytokine, which drives a negative feedback process during inflammation 
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(Kwilasz et al., 2015). The major roles of TNF-α and other inflammatory 
cytokines in the progression of metabolic complications are likely to be 
related to oxidative stress (Rolo et al., 2012). Indeed, ROS and products of 
lipid peroxidation activate nuclear factor-ƙB, which induces the synthesis 
of TNF-α and increases the expression of several pro-inflammatory 
cytokines, leading to metabolic diseases (Rolo et al., 2012; Hernandez-
Aguilera et al., 2013). The recognized link among inflammation, redox 
status, and mitochondrial function prompted us to evaluate the effect of 
dietary regimens on mitochondrial oxidative capacity and oxidative stress 
in liver mitochondria in view of the central role played by this organ in 
energy metabolism. The LFM- and HFM-fed rats exhibited higher hepatic 
mitochondrial respiratory capacity than did rats in the control group. 
However, compared with the LFM group, the HFM group exhibited an 
increased rate of mitochondrial fatty acid oxidation due to enhanced 
activity of CPT, the rate-limiting enzyme for fatty acid entry into the 
mitochondria. Thus, the consequent increase in lipid oxidation explains the 
decreased load of hepatic lipid content found in these rats. Interestingly, 
compared with the LFM group, in the HFM group we observed a reduction 
of oxidative stress, as indicated by a decrease in H2O2 production and an 
increase in activities of aconitase and SOD. A concomitant decline in 
mitochondrial energy efficiency (thermogenic effect), as evidenced by 
increased proton leakage, may also contribute to burn fat and reduce 
mitochondrial oxidative stress parameters. Indeed, an increase in proton 
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leakage was reported as one of the major mechanisms involved in the 
modulation of membrane potential to control mitochondrial ROS emission 
(Mailloux and Harper, 2011). 
 In conclusion, our data provide the first evidence that dietary 
supplementation with HFM in a rat animal model decreased liver lipid 
accumulation through an increase in fatty acid oxidation, and decreased 
inflammation and oxidative stress. The beneficial effects of HFM are 
similar to those resulting from n-3 PUFA and CLA intake (Lionetti et al., 
2014; Mollica et al., 2014; Cavaliere et al., 2016), allowing us to 
hypothesize that n-3 PUFA and CLA may be some of the key components 
of HFM. Further studies will be addressed to verify the specific role of 
these components. 
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Figure 4.1 Body composition and energy balance of rats fed with milk 
from cows consuming a low forage (LFM) or high forage (HFM) diet: 
 
 
(A) water, (B) body lipid, (C) body energy, (D) body protein, (E) hepatic lipid content, (F) energy 
intake, (G) BW gain, (H) lipid gain, (I) protein gain, (L) energy expenditure, and (M) energy 
efficiency (means ± SE; n = 7 animals/group). Different letters indicate statistically significant 
differences between treatment groups (P < 0.05).  
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Figure 4.2 Serum metabolites, inflammatory parameters, and glucose 
and insulin tolerance test in rats fed with milk from cows consuming a 
low forage (LFM) or high forage (HFM) diet: 
 
(A) leptin (L), (B) adiponectin (A), (C) leptin:adiponectin (L/A) ratio, (D) tumor necrosis factor-α 
(TNF-α), (E) IL-1, (F) IL-10, (G) plasma glucose concentration, (H) plasma insulin concentration at 
different times after glucose load (oral glucose tolerance test), and (I) plasma glucose concentration 
at different times after insulin injection (insulin tolerance test). In panels G, H, and I, the upper inset 
shows the area under curve (AUC) for each group (mean ± SE; n = 7 animals/group). Different 
letters indicate statistically significant differences between treatment groups (P < 0.05).  
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Figure 4.3. Mitochondrial parameters of rats fed with milk from cows 
consuming a low forage (LFM) or high forage (HFM) diet: 
 
(A and B) hepatic mitochondria respiration rates at states 3 and 4 in the presence of succinate (A) or 
palmitoyl-carnitine (B) substrates; (C) carnitinepalmitoyl transferase (CPT) activity; (D) basal and 
(E) fatty acid-induced proton-leakage; (F) intracellular H2O2 yield, (G) basal aconitase/ total 
aconitase ratio, and (H) superoxide dismutase (SOD) activity (means ± SE from 7 animals/group). 
Different letters indicate statistically significant differences between treatment groups (P < 0.05). 
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CHAPTER V 
 
CONCLUSION AND FUTURE DIRECTIONS 
 
Progress in learning how to direct the mitochondrial energy balance rests 
upon a foundation of knowledge gained over the past two decades 
concerning the mechanisms of metabolic disorder development, and most 
of this information has been gained from studies in mice. However, as our 
understanding of mitochondrial energy balance mechanisms upon dietary 
fats in the mouse has expanded, it has become apparent that greater efforts 
must be made to translate this information into new human nutritional 
therapies.  
 
Numerous prior studies have shown the central importance of nutrients on 
metabolic disorders. It is widely believed that developing our 
understanding of the mechanisms regulating skeletal muscle metabolism 
will allow development of novel therapeutic targets for the treatment of 
metabolic disorders.  
 
Dietary fat sources may differentially affect the development of 
inflammation in insulin-sensitive tissues during chronic 
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overfeeding. Considering the anti-inflammatory properties of ω-3 fatty 
acids, this thesis aimed to compare the effects of high-fish oil and high-lard 
diets on obesity-related inflammation by evaluating serum following with 
the effects of High forage milk and low forage milk in insulin-sensitive 
tissues (skeletal muscle and liver).  
 
In Paper I, our data strengthened the association of high dietary ω3-PUFA 
intake with reduced mitochondrial energy efficiency in the skeletal muscle. 
FD rats showed lower weight, lipid gain and energy efficiency compared 
to LD-fed animals, showing higher energy expenditure and O2 
consumption/CO2 production. Serum lipid profile and pro-inflammatory 
parameters in FD-fed animals were reduced compared to LD. 
Accordingly, FD rats exhibited a higher glucose tolerance revealed by an 
improved glucose and insulin tolerance tests compared to LD, 
accompanied by a restoration of insulin signalling in skeletal muscle. 
PUFAs increased lipid oxidation and reduced energy efficiency in 
subsarcolemmal mitochondria, and increase AMPK activation, reducing 
both endoplasmic reticulum and oxidative stress. Increased mitochondrial 
respiration was related to an increased mitochondriogenesis in FD skeletal 
muscle, as shown by the increase in PGC1-α and -β. 
 
In paper II, to explore changes in liver mitochondria our choice was to 
follow the impact of High forage milk with replacement of low forage milk 
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in order to observe our important preferences since High forage milk is 
rich in ω3-PUFA. We observed the attenuated development of tissue 
inflammation degree and insulin resistance in the liver mitochondria. In 
conclusion, our data indicate that the substitution of saturated by 
unsaturated fatty acids in the diet has beneficial effects on modulation of 
inflammation and mitochondrial function in obesity. 
 
Continued research to uncover novel mechanisms of action and establish 
potential therapeutic targets is expected to provide new opportunities for 
prevention or treatment of inflammation, skeletal muscle insulin resistance 
and metabolic dysfunction. 
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